Private area
Contact Us
Total Visits
| Views | |
|---|---|
| Afatinib ... | 173 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Afatinib ... | 0 | 16 | 5 | 5 | 12 | 8 | 0 |
File Visits
| Views | |
|---|---|
| afatinib_versus_erlotinib_as_second_line_treatment_patients_advanced_squamous_cell_carcinoma_lung_final_analysis_randomised_phase_3_lux_lung_8_trial_2021.pdf | 50 |
| afatinib_versus_erlotinib_as_second_line_treatment_patients_advanced_squamous_cell_carcinoma_lung_final_analysis_randomised_phase_3_lux_lung_8_trial_2021_material_suplementari2.pdf | 43 |
| afatinib_versus_erlotinib_as_second_line_treatment_patients_advanced_squamous_cell_carcinoma_lung_final_analysis_randomised_phase_3_lux_lung_8_trial_2021_material_suplementari3.pdf | 34 |
| afatinib_versus_erlotinib_as_second_line_treatment_patients_advanced_squamous_cell_carcinoma_lung_final_analysis_randomised_phase_3_lux_lung_8_trial_2021_material_suplementari1.pdf | 33 |
Top country views
| Views | |
|---|---|
| United States | 64 |
| Singapore | 20 |
| Brazil | 16 |
| China | 13 |
| United Kingdom | 8 |
| Japan | 5 |
| Germany | 4 |
| Uzbekistan | 4 |
| Austria | 3 |
| Spain | 3 |
Top cities views
| Views | |
|---|---|
| Singapore | 18 |
| Ashburn | 9 |
| Beijing | 8 |
| Portsmouth | 6 |
| Atlanta | 3 |
| Buffalo | 3 |
| Dublin | 3 |
| Seattle | 3 |
| Tashkent | 3 |
| Almont | 2 |
